The N-Terminus Makes the Difference: Impact of Genotype-Specific Disparities in the N-Terminal Part of The Hepatitis B Virus Large Surface Protein on Morphogenesis of Viral and Subviral Particles.
Adult
Black or African American
/ genetics
Asian People
/ genetics
Cell Line, Tumor
DNA, Viral
/ blood
Female
Genotype
Hepatitis B Surface Antigens
/ genetics
Hepatitis B virus
/ genetics
Hepatitis B, Chronic
/ blood
Humans
Male
Middle Aged
Morphogenesis
Protein Domains
/ genetics
Protein Precursors
/ genetics
Viral Envelope Proteins
/ chemistry
Virion
/ growth & development
White People
/ genetics
HBV filaments
HBV genotypes
HBV surface protein
PreS1 deletion
morphogenesis
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
13 08 2020
13 08 2020
Historique:
received:
28
06
2020
revised:
27
07
2020
accepted:
11
08
2020
entrez:
23
8
2020
pubmed:
23
8
2020
medline:
20
3
2021
Statut:
epublish
Résumé
The N-terminus of the hepatitis B virus (HBV) large surface protein (LHB) differs with respect to genotypes. Compared to the amino terminus of genotype (Gt)D, in GtA, GtB and GtC, an additional identical 11 amino acids (aa) are found, while GtE and GtG share another similar 10 aa. Variants of GtB and GtC affecting this N-terminal part are associated with hepatoma formation. Deletion of these amino-terminal 11 aa in GtA reduces the amount of LHBs and changes subcellular accumulation (GtA-like pattern) to a dispersed distribution (GtD-like pattern). Vice versa, the fusion of the GtA-derived N-terminal 11 aa to GtD causes a GtA-like phenotype. However, insertion of the corresponding GtE-derived 10 aa to GtD has no effect. Deletion of these 11aa decreases filament size while neither the number of released viral genomes nor virion size and infectivity are affected. A negative regulatory element (aa 2-8) and a dominant positive regulatory element (aa 9-11) affecting the amount of LHBs were identified. The fusion of this motif to eGFP revealed that the effect on protein amount and subcellular distribution is not restricted to LHBs. These data identify a novel region in the N-terminus of LHBs affecting the amount and subcellular distribution of LHBs and identify release-promoting and -inhibiting aa residues within this motive.
Identifiants
pubmed: 32823751
pii: cells9081898
doi: 10.3390/cells9081898
pmc: PMC7463600
pii:
doi:
Substances chimiques
DNA, Viral
0
Hepatitis B Surface Antigens
0
L protein, hepatitis B virus
0
Protein Precursors
0
Viral Envelope Proteins
0
presurface protein 1, hepatitis B surface antigen
0
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Intervirology. 2014;57(3-4):141-50
pubmed: 25034481
J Virol. 2018 Jun 29;92(14):
pubmed: 29743374
J Virol. 2009 Aug;83(16):8032-40
pubmed: 19515776
Vaccine. 2020 Mar 30;38(15):3105-3120
pubmed: 32113806
Cell. 1989 Dec 22;59(6):1145-56
pubmed: 2598264
J Biol Chem. 2006 Sep 29;281(39):29297-308
pubmed: 16867982
J Virol. 2015 Dec 30;90(7):3330-41
pubmed: 26719264
World J Gastroenterol. 2007 Jan 7;13(1):65-73
pubmed: 17206755
J Virol. 1999 Mar;73(3):2052-7
pubmed: 9971786
Aliment Pharmacol Ther. 2019 Oct;50(8):940-954
pubmed: 31240738
Clin Microbiol Rev. 2007 Jul;20(3):426-39, table of contents
pubmed: 17630333
Virology. 1996 Apr 15;218(2):396-9
pubmed: 8610467
J Gastroenterol Hepatol. 2018 Jul;33(7):1370-1378
pubmed: 29232004
J Med Virol. 2005 Jun;76(2):194-202
pubmed: 15834881
Virus Res. 2016 Jan 4;211:209-21
pubmed: 26541316
J Gastroenterol Hepatol. 2014 Apr;29(4):843-50
pubmed: 24783251
J Virol. 2005 Feb;79(3):1613-22
pubmed: 15650187
Virology. 1995 Nov 10;213(2):292-9
pubmed: 7491754
Eur J Biochem. 2004 Feb;271(4):863-74
pubmed: 14764103
Aliment Pharmacol Ther. 2018 Jun;47(11):1523-1535
pubmed: 29637585
Virology. 2007 Aug 15;365(1):204-9
pubmed: 17462692
J Virol. 1995 Nov;69(11):6652-7
pubmed: 7474074
World J Gastroenterol. 2015 Apr 28;21(16):5039-48
pubmed: 25945020
Hepatology. 2005 Dec;42(6):1300-9
pubmed: 16317706
J Virol. 1984 Nov;52(2):396-402
pubmed: 6492255
Gut. 2020 Jun 22;:
pubmed: 32571971
J Virol. 2010 Feb;84(4):1989-2000
pubmed: 20007265
J Virol. 1990 Feb;64(2):613-20
pubmed: 2153228
J Med Virol. 2005 Jan;75(1):13-9
pubmed: 15543574
J Hepatol. 2016 Apr;64(1 Suppl):S4-S16
pubmed: 27084035
J Med Virol. 2008 Jul;80(7):1189-94
pubmed: 18461612
FEBS Lett. 2006 Jan 23;580(2):575-80
pubmed: 16405965
Arch Virol Suppl. 1992;4:129-32
pubmed: 1450681
J Virol. 1987 May;61(5):1672-7
pubmed: 3573147
J Virol. 2008 Aug;82(16):7812-7
pubmed: 18524834
Virology. 1996 Nov 1;225(1):235-9
pubmed: 8918553
J Clin Virol. 2016 Sep;82:27-32
pubmed: 27415434